Ankara Hastanesi
Prof. Dr. Kayser ÇAĞLAR
Canlı Destek’e Bağlan
Sizi Arayalım
UZMANLIKLAR
Hastalıkları
- Hipertansiyon
- Üriner enfeksiyonlar
- Böbrek yetmezlikleri
- Nefritler
- Sıvı elektrolit bozuklukları
GÖREV ALDIĞI DİĞER HASTANE VE BİRİMLER
-
Ankara Hastanesiİç Hastalıkları (Dahiliye)
KİŞİSEL BİLGİLER
DENEYİM
2025 - Halen, Istanbul/Türkiye
MEMORİAL ANKARA HASTANESİ
Nefroloji Uzmanı
2016 - 2025, Ankara/Türkiye
LÖSANTE HASTANESİ
Nefroloji Uzmanı
2013 - 2016, Ankara/Türkiye
MEMORİAL ANKARA HASTANESİ
Nefroloji Uzmanı
2000 - 2001, Nashville/Amerika
VANDERBİLT UNİVERSİTY
Nefroloji Uzmanı
1995 - 2013, Ankara/Türkiye
GATA NEFROLOJİ BİLİM DALI
Asistanlık, Uzmanlık, Öğretim Üyeliği
1993 - 1995, Ağrı/Türkiye
AĞRI ASKER HASTANESİ
İç Hastalıkları Uzmanı
1989 - 1993, Ankara/Türkiye
GATA İÇ HASTALIKLARI BİLİM DALI
İç hastalıkları ihtisas
1987 - 1989, KKTC/KKTC
KKTC
Pratisyen Hekim
EĞİTİM
1980 - 1986, Ankara
GATA Tıp Fakültesi
BİLİMSEL YAYINLARI
- 1: Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E,
Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A. Red cell
distribution width is independently related to endothelial dysfunction in
patients with chronic kidney disease. Am J Med Sci. 2014 Feb;347(2):118-24. doi:
10.1097/MAJ.0b013e3182996a96. PMID: 23928544.
- 2: Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y,
-
Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M. Mean corpuscular volume
is associated with endothelial dysfunction and predicts composite cardiovascular
events in patients with chronic kidney disease. Nephrology (Carlton). 2013
Nov;18(11):728-35. doi: 10.1111/nep.12130. PMID: 23848392.
- 3: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M,
-
Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C.
Longitudinal analysis of vascular function and biomarkers of metabolic bone
disorders before and after renal transplantation. Am J Nephrol.
2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31. PMID: 23391995.
- 4: Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K,
-
Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ.
Neutrophil to lymphocyte ratio independently predicts cardiovascular events in
patients with chronic kidney disease. Clin Exp Nephrol. 2013 Aug;17(4):532-40.
doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20. PMID: 23180042.
- 5: Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E,
-
Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum uric acid
-
independently predicts cardiovascular events in advanced nephropathy. Am J
Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22. PMID:
23007099.
- 6: Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K,
-
Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.
Relationship between serum magnesium levels and cardiovascular events in chronic
kidney disease patients. Am J Nephrol. 2012;36(3):228-37. doi:
10.1159/000341868. Epub 2012 Aug 30. PMID: 22948239.
- 7: Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU,
-
Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic
kidney disease: a novel risk factor? Int Urol Nephrol. 2013 Feb;45(1):151-6.
doi: 10.1007/s11255-012-0158-4. Epub 2012 Mar 23. PMID: 22437807.
- 8: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz
-
Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Comparison of calcium acetate
and sevelamer on vascular function and fibroblast growth factor 23 in CKD
patients: a randomized clinical trial. Am J Kidney Dis. 2012 Feb;59(2):177-85.
doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2. PMID: 22137672.
- 9: Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T,
-
Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.
Endogenous testosterone, endothelial dysfunction, and cardiovascular events in
men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011
-
Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23. PMID: 21700826.
- 10: Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T,
-
Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ. Vascular
health, systemic inflammation and progressive reduction in kidney function;
clinical determinants and impact on cardiovascular outcomes. Nephrol Dial
Transplant. 2011 Nov;26(11):3537-43. doi: 10.1093/ndt/gfr081. Epub 2011 Mar 4.
PMID: 21378154.
- 11: Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz
-
Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ.
Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial
dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011
Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17. PMID: 21330486;
PMCID: PMC3069370.
- 12: Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten
-
T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Low triiodothyronine alters
flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J
Nephrol. 2011;33(1):25-32. doi: 10.1159/000322581. Epub 2010 Dec 9. PMID:
21150192.
- 13: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T,
-
Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. FGF-23 and vascular
dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int.
-
2010 Oct;78(7):679-85. doi: 10.1038/ki.2010.194. Epub 2010 Jul 7. PMID:
20613714.
- 14: Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu
-
M, Yilmaz MI. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on
visfatin levels in diabetic nephropathy. Nephrology (Carlton). 2010
Mar;15(2):225-9. doi: 10.1111/j.1440-1797.2009.01173.x. PMID: 20470283.
- 15: Afsar B, Afsar RE, Sen ST, Kirkpantur A, Eyileten T, Yilmaz MI, Caglar K.
-
Simple renal cysts and circadian blood pressure: are they related to each other
in patients with hypertension? Int Urol Nephrol. 2011 Mar;43(1):157-65. doi:
10.1007/s11255-010-9734-7. Epub 2010 Apr 13. PMID: 20390353.
- 16: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Cayci T, Kilic S, Eyileten T, Caglar
-
K, Oguz Y, Vural A, Yenicesu M, Axelsson J. Reduced proteinuria using ramipril
in diabetic CKD stage 1 decreases circulating cell death receptor activators
concurrently with ADMA. A novel pathophysiological pathway? Nephrol Dial
Transplant. 2010 Oct;25(10):3250-6. doi: 10.1093/ndt/gfq159. Epub 2010 Mar 26.
PMID: 20348148.
- 17: Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten
- doi: 10.1159/000272936. Epub 2009 Dec 31. PMID: 20068285
T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid
artery intima-media thickness in chronic kidney disease and kidney transplant
patients without overt cardiovascular disease. Am J Nephrol. 2010;31(3):214-21.
- 18: Sonmez A, Yilmaz MI, Saglam M, Kilic S, Eyileten T, Uckaya G, Caglar K, Oguz
-
Y, Vural A, Yenicesu M, Kutlu M, Kinalp C, Zoccali C. The relationship between
hemoglobin levels and endothelial functions in diabetes mellitus. Clin J Am Soc
Nephrol. 2010 Jan;5(1):45-50. doi: 10.2215/CJN.05080709. Epub 2009 Oct 15. PMID:
19833907; PMCID: PMC2801645.
- 19: Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K. Antibody response
-
following hepatitis B vaccination in dialysis patients: does depression and life
quality matter? Vaccine. 2009 Sep 25;27(42):5865-9. doi:
10.1016/j.vaccine.2009.07.055. Epub 2009 Aug 3. PMID: 19654067.
- 20: Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A,
-
Oguz Y, Aslan I, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J.
Normalization of endothelial dysfunction following renal transplantation is
accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of
endothelial damage? Clin Transplant. 2009 Mar-Apr;23(2):241-8. doi:
10.1111/j.1399-0012.2008.00921.x. PMID: 19402217.
- 21: Yilmaz MI, Sonmez A, Saglam M, Gulec M, Kilic S, Eyileten T, Caglar K, Oguz
-
Y, Vural A, Yenicesu M, Zoccali C. Hemoglobin is inversely related to flow-
mediated dilatation in chronic kidney disease. Kidney Int. 2009
Jun;75(12):1316-1321. doi: 10.1038/ki.2009.63. Epub 2009 Mar 4. PMID: 19262460.
- 22: Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K,
-
Kirkpantur A, Celik T, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P.
Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2
-
diabetic patients with proteinuria. Clin J Am Soc Nephrol. 2009 Mar;4(3):535-41.
doi: 10.2215/CJN.04330808. Epub 2009 Feb 11. PMID: 19211665; PMCID: PMC2653664.
- 23: Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C, Yenicesu M,
-
Vural A. The relationship between adiponectin levels and degree of proteinuria
in patients with nephrotic and non-nephrotic proteinuria. Ren Fail.
2009;31(1):29-35. doi: 10.1080/08860220802546461. PMID: 19142807.
- 24: Beyzadeoglu M, Arpaci F, Surenkok S, Ozyigit G, Oysul K, Caglar K, Ataergin
-
S, Yenicesu M, Kaya A. Acute renal toxicity of 2 conditioning regimens in
patients undergoing autologous peripheral blood stem-cell transplantation. Total
body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Saudi Med J. 2008 Jun;29(6):832-6. PMID: 18521460.
- 25: Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Sonmez A, Eyileten T,
-
Yenicesu M, Oguz Y, Tasar M, Vural A, Ikizler TA, Stenvinkel P, Lindholm B.
Serum fetuin-a concentration and endothelial dysfunction in chronic kidney
disease. Nephron Clin Pract. 2008;108(3):c233-40. doi: 10.1159/000120209. Epub
2008 Mar 11. PMID: 18334823.
- 26: Yilmaz MI, Sonmez A, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T,
- 10.1681/ASN.2007040461. Epub 2008 Jan 16. PMID: 18199801; PMCID: PMC2396733
Cakir E, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. ADMA
levels correlate with proteinuria, secondary amyloidosis, and endothelial
dysfunction. J Am Soc Nephrol. 2008 Feb;19(2):388-95. doi:
- 27: Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A,
-
Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J.
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is
associated with low circulating adiponectin. Nephrol Dial Transplant. 2008
May;23(5):1621-7. doi: 10.1093/ndt/gfm828. Epub 2008 Jan 5. PMID: 18175782.
- 28: onmez A, Yilmaz MI, Korkmaz A, Topal T, Caglar K, Kaya A, Eyileten T,
-
Yenicesu M, Oguz Y, Basal S, Ipcioglu OM, Vural A. Hyperbaric oxygen treatment
augments the efficacy of cilazapril and simvastatin regimens in an experimental
nephrotic syndrome model. Clin Exp Nephrol. 2008 Apr;12(2):110-118. doi:
10.1007/s10157-007-0017-2. Epub 2008 Jan 5. PMID: 18175058.
- 29: Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M,
-
Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term
treatment with sevelamer increases serum fetuin-a concentration and improves
endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am
Soc Nephrol. 2008 Jan;3(1):61-8. doi: 10.2215/CJN.02810707. Epub 2007 Dec 5.
PMID: 18057307; PMCID: PMC2390988.
- 30: Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A,
-
Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. Serum visfatin
concentration and endothelial dysfunction in chronic kidney disease. Nephrol
Dial Transplant. 2008 Mar;23(3):959-65. doi: 10.1093/ndt/gfm727. Epub 2007 Nov
4. PMID: 17984105.
- 31: Kara B, Caglar K, Kilic S. Nonadherence with diet and fluid restrictions and
-
perceived social support in patients receiving hemodialysis. J Nurs Scholarsh.
2007;39(3):243-8. doi: 10.1111/j.1547-5069.2007.00175.x. PMID: 17760797.
- 32: Yilmaz I, Saglam M, Sonmez A, Caglar K, Cakir E, Kurt Y, Eyileten T, Tasar
-
M, Acikel C, Oguz Y, Vural A, Yenicesu M. Improving proteinuria, endothelial
functions and asymmetric dimethylarginine levels in chronic kidney disease:
ramipril versus valsartan. Blood Purif. 2007;25(4):327-35. doi:
10.1159/000107410. Epub 2007 Aug 20. PMID: 17709915.
- 33: Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C,
-
Oguz Y, Yavuz I, Vural A. Effect of antihypertensive agents on plasma
adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology
(Carlton). 2007 Apr;12(2):147-53. doi: 10.1111/j.1440-1797.2007.00764.x. PMID:
17371337.
- 34: Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Eyileten T, Sonmez A, Oguz
-
Y, Oner K, Ors F, Vural A, Yenicesu M. Endothelial dysfunction and fetuin A
levels before and after kidney transplantation. Transplantation. 2007 Feb
27;83(4):392-7. doi: 10.1097/01.tp.0000251647.72673.c7. PMID: 17318070.
- 35: Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T,
- 16820789
Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C. ADMA, proteinuria,
and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney
Int. 2006 Aug;70(4):781-7. doi: 10.1038/sj.ki.5001632. Epub 2006 Jul 5. PMID:
- 36: Oguz Y, Yilmaz MI, Eyileten T, Caglar K, Yenicesu M, Kaya A, Tasar M, Saglam
-
M, Doganci L, Gulec B, Oner K, Oktenli C, Vural A. Persistent mediastinal and
axillary lymph node tuberculosis in a renal transplant patient with successful
outcome. Transplant Proc. 2006 Jun;38(5):1336-40. doi:
10.1016/j.transproceed.2006.03.038. PMID: 16797296.
- 37: Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K. Association of
-
plasma adiponectin concentrations with chronic lymphocytic leukemia and
myeloproliferative diseases. Int J Hematol. 2006 Apr;83(3):254-8. doi:
10.1532/IJH97.NA0411. PMID: 16720558.
- 38: Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T,
-
Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA.
Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an
experimental nephrotic syndrome model. Nephron Exp Nephrol. 2006;104(1):e15-22.
doi: 10.1159/000093260. Epub 2006 May 11. PMID: 16699289.
- 39: Yilmaz MI, Saglam M, Caglar K, Cakir E, Ozgurtas T, Sonmez A, Eyileten T,
-
Yenicesu M, Acikel C, Oguz Y, Ozcan O, Bozlar U, Erbil K, Aslan I, Vural A.
Endothelial functions improve with decrease in asymmetric dimethylarginine
(ADMA) levels after renal transplantation. Transplantation. 2005 Dec
27;80(12):1660-6. doi: 10.1097/01.tp.0000183750.22675.be. PMID: 16378057.
- 40: Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A,
-
Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C.
-
The determinants of endothelial dysfunction in CKD: oxidative stress and
asymmetric dimethylarginine. Am J Kidney Dis. 2006 Jan;47(1):42-50. doi:
10.1053/j.ajkd.2005.09.029. PMID: 16377384.
- 41: Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Kir T, Acikel C,
-
Bingol N, Oguz Y, Ikizler TA, Vural A. Adiponectin level is reduced and
inversely correlated with the degree of proteinuria in type 2 diabetic patients.
Clin Nephrol. 2005 Jul;64(1):12-9. doi: 10.5414/cnp64012. PMID: 16047640.
- 42: Vural A, Yilmaz MI, Caglar K, Aydin A, Sonmez A, Eyileten T, Acikel C, Gulec
-
B, Kozak O, Oner K. Assessment of oxidative stress in the early posttransplant
period: comparison of cyclosporine A and tacrolimus-based regimens. Am J
Nephrol. 2005 May-Jun;25(3):250-5. doi: 10.1159/000086079. Epub 2005 May 27.
PMID: 15925859.
- 43: Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer
-
and adiponectin. Urology. 2005 Jun;65(6):1168-72. doi:
10.1016/j.urology.2004.12.053. PMID: 15922427.
- 44: Yilmaz MI, Sonmez A, Caglar K, Gok DE, Eyileten T, Yenicesu M, Acikel C,
- 45: Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S,
-
Bingol N, Kilic S, Oguz Y, Vural A. Peroxisome proliferator-activated receptor
gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2
diabetic patients with proteinuria. Endocrine. 2004 Dec;25(3):207-14. doi:
10.1385/ENDO:25:3:207. PMID: 15758247.
Bingol N, Bingol S, Vural A. Blockade of the renin-angiotensin system increases
plasma adiponectin levels in type-2 diabetic patients with proteinuria. Nephron
Clin Pract. 2005;99(4):c115-21. doi: 10.1159/000083929. Epub 2005 Feb 10. PMID:
15711099.
- 46: Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA. Uremic malnutrition is a
-
predictor of death independent of inflammatory status. Kidney Int. 2004
Nov;66(5):2054-60. doi: 10.1111/j.1523-1755.2004.00978.x. PMID: 15496179.
- 47: Demirkiliç U, Kuralay E, Yenicesu M, Cağlar K, Oz BS, Cingöz F, Günay C,
-
Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H. Timing of replacement therapy
for acute renal failure after cardiac surgery. J Card Surg. 2004 Jan-
Feb;19(1):17-20. doi: 10.1111/j.0886-0440.2004.04004.x. PMID: 15108784.
glar K, Odabasi Z, Safali M, Yenicesu M, Vural A. Colchicine-induced
-
myopathy with myotonia in a patient with chronic renal failure. Clin Neurol
Neurosurg. 2003 Sep;105(4):274-6. doi: 10.1016/s0303-8467(03)00030-1. PMID:
12954545.
- 49: Caglar K, Hakim RM, Ikizler TA. Approaches to the reversal of malnutrition,
-
inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev. 2002
Nov;60(11):378-87. doi: 10.1301/00296640260385928. PMID: 12462522.
- 50: Caglar K, Kinalp C, Arpaci F, Turan M, Saglam K, Ozturk B, Komurcu S, Yavuz
-
I, Yenicesu M, Ozet A, Vural A. Cumulative prior dose of cisplatin as a cause of
-
the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell
transplantation. Nephrol Dial Transplant. 2002 Nov;17(11):1931-5. doi:
10.1093/ndt/17.11.1931. PMID: 12401849.
- 51: Caglar K, Safali M, Yavuz I, Odabaşi Z, Yenicesu M, Vural A. Colchicine-
-
induced myopathy with normal creatine phosphokinase level in a renal transplant
patient. Nephron. 2002 Dec;92(4):922-4. doi: 10.1159/000065439. PMID: 12399640.
- 52: Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA.
-
Inflammatory signals associated with hemodialysis. Kidney Int. 2002
Oct;62(4):1408-16. doi: 10.1111/j.1523-1755.2002.kid556.x. PMID: 12234313.
- 53: Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic
-
effects of oral nutritional supplementation during hemodialysis. Kidney Int.
2002 Sep;62(3):1054-9. doi: 10.1046/j.1523-1755.2002.00530.x. PMID: 12164890.
- 54: Pupim LB, Kent P, Caglar K, Shyr Y, Hakim RM, Ikizler TA. Improvement in
-
nutritional parameters after initiation of chronic hemodialysis. Am J Kidney
Dis. 2002 Jul;40(1):143-51. doi: 10.1053/ajkd.2002.33923. PMID: 12087572.
- 55: Caglar K, Orhan ME, Gulec B, Yavuz I, Yenicesu M, Guzeldemir E, Vural A.
- 56: Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural
-
Severe rhabdomyolysis due to malignant hyperthermia during renal transplantation
- 57: Cağlar K, Kibar Y, Tahmaz L, Safali M. Laser therapy in patient with
-
intractable haemorrhage due to the bladder involvement of systemic amyloidosis.
-
Mediterranean fever. Clin Exp Rheumatol. 2000 Nov-Dec;18(6):787-8. PMID:
11138354.
- 60: Vural A, Oguz Y, Oktenli C, Yenicesu M, Caglar K, Tanboga H. Detection of
-
source of haematuria after extracorporeal shock wave lithotripsy (ESWL) by
automated measurement of urinary red cell volume. Int Urol Nephrol.
1998;30(1):31-7. doi: 10.1007/BF02550274. PMID: 9569108.
- 61: Bulucu F, Vural A, Yenicesu M, Caglar K. Association of Gitelman's syndrome
-
and focal glomerulosclerosis. Nephron. 1998;79(2):244. doi: 10.1159/000045043.
PMID: 9647519.
Nephrol Dial Transplant. 2001 Aug;16(8):1724. doi: 10.1093/ndt/16.8.1724. PMID:
11477190.
- 58: Caglar K, Kibar Y, Tahmaz L, Tekin A, Yenicesu M, Vural A. Polycystic
- 59: Dinc A, Simsek I, Pay S, Caglar K, Can C. Fabry's disease mimicking familial
-
horseshoe kidney. Clin Nephrol. 2001 Jun;55(6):487-8. PMID: 11434362.
procedure can cause delayed graft function. Am J Nephrol. 2002 Jan-Feb;22(1):81-3. doi: 10.1159/000046678. PMID: 11919407.
MESLEKİ ÜYELİKLER
- Türk Nefroloji Derneği
- Türk Hipertansiyon ve Böbrek Hastalıklar Derrneği
- European Renal Association Üyeliği
Mesleki Ödül, Derece ve Deneyimler
Katıldığı Mesleki Eğitimler, Kurslar ve Konferanslar
Fiyat Sor
Fiyat bilgisi almak için aşağıdaki formu doldurun.
Sosyal Medya Hesaplarımız
